These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

120 related items for PubMed ID: 4974096

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. [Restoration of drug sensitivity in Mycobacterium tuberculosis to streptomycin and isoniazid during treatment with preparations of the 1st series].
    Rudoĭ NM, Utkin VV, Fedorova IE, Afanas'eva IuP.
    Antibiotiki; 1970 Apr; 15(4):355-7. PubMed ID: 4993044
    [No Abstract] [Full Text] [Related]

  • 5. Ethionamide plus thiacetazone in pulmonary tuberculosis resistant to first-line drugs.
    Narang RK, Sarin JN.
    J Assoc Physicians India; 1966 Aug; 14(8):503-6. PubMed ID: 5914879
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [Resistance of tubercle bacilli to cycloserine, viomycin and ethionamide in patients suffering from pulmonary tuberculosis].
    Srednicka-Zajac D, Mysakowska H, Szarewicz-Adamczyk W, Litwin B.
    Ann Univ Mariae Curie Sklodowska Med; 1967 Aug; 22():71-8. PubMed ID: 4308440
    [No Abstract] [Full Text] [Related]

  • 8. [Clinical and bacteriological problems of ethionamide therapy].
    Lányi M.
    Z Tuberk Erkr Thoraxorg; 1965 Jul; 123(4):332-4. PubMed ID: 5897862
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [Primary drug resistance of Mycobacterium tuberculosis to 2d line preparations].
    Fedotova ZN, Gur'ian IE, Kochetov BI.
    Probl Tuberk; 1972 Jul; 50(11):21-4. PubMed ID: 4630564
    [No Abstract] [Full Text] [Related]

  • 11. Position of cycloserine in the treatment of pulmonary tuberculosis.
    Meyer A, Nadjar G.
    Scand J Respir Dis Suppl; 1970 Jul; 71():139-43. PubMed ID: 5271974
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [Intravenous hormono-chemotherapy of pulmonary tuberculosis in case of drug-resistant mycobacteria].
    Repin IuM, Saburenkova EP.
    Vrach Delo; 1969 Feb; 2():61-3. PubMed ID: 4305290
    [No Abstract] [Full Text] [Related]

  • 15. Results of one-year chemotherapy with isoniazid (INH), streptomycin (SM) and ethionamide (ETA) in previously untreated patients with cavernous pulmonary tuberculosis.
    Zajaczkowska J, Krychniak W, Krakówka P, Buraczewska M.
    Pol Med J; 1966 Feb; 5(2):339-44. PubMed ID: 5915720
    [No Abstract] [Full Text] [Related]

  • 16. [Resistance of Mycobacterium tuberculosis, the extent of isoniazid inactivation and blood bacteriostatic activity in chemotherapy of pulmonary tuberculosis].
    Tipp ZI.
    Probl Tuberk; 1969 Feb; 47(8):76-9. PubMed ID: 4987468
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Cycloserine in the treatment of pulmonary tuberculosis.
    Aceves Ortega R, Cortés de la Peña F, Sanchez Ceceña S, Arreola Chavez C.
    Scand J Respir Dis Suppl; 1970 Feb; 71():109-14. PubMed ID: 5271969
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.